Summary Keywords lipid control, metabolic indices, semaglutide, vitamin D, weight loss Citation Israel A, Moed M, Abo Fanne H, Kedem A, Odeh M, Rashed KA, Marzook T, Abumouch I and Fanne RA (2026) Baseline vitamin D status is associated with glycemic and weight loss outcomes in patients with type 2 diabetes treated with semaglutide
While diabetes is a known driver of kidney damage, obesity alone can lead to similar issues through mechanisms like increased pressure within the kidneys, inflammation, and oxidative stress
Starting at a low dosesuch as the 0.25 mg starter dose in the STEP trialshelps reduce the intensity of early side effects
However, optimal results develop within four to six weeks
They can check your health and risk factors to suggest whats best for you
Now, a new study published in Led by researchers from the University of Pennsylvania, the study examined more than 400,000 Reddit posts from nearly 70,000 users discussing GLP-1 receptor agonists, including semaglutide and tirzepatide